The total return over the past 12 months is -16.90% vs. +17.49% for the S&P 500. So far it's up -11.30% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (20.69%) | (24.42%) | (2.85%) | +6.94% | +10.08% | +13.10% |
| Total Return CAGR | (16.90%) | (22.25%) | (0.65%) | +9.46% | +12.53% | +15.47% |
| Revenue CAGR | +11.20% | +21.35% | +19.76% | +11.98% | +10.26% | +11.28% |
| Net Income CAGR | +10.26% | +23.58% | +20.61% | +12.85% | +12.87% | +15.76% |
| EPS CAGR | +10.48% | +27.16% | +19.59% | +13.88% | +15.01% | +17.60% |
| Free Cash Flow CAGR | (20.75%) | (8.48%) | (1.45%) | +3.09% | +5.78% | +11.41% |
| Operating Cash Flow CAGR | +12.71% | +17.37% | +19.08% | +12.05% | +11.76% | +14.05% |
| Dividends CAGR | +4.04% | +20.43% | +19.54% | +9.79% | +16.21% | +19.85% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Novo Nordisk A/S (NVO)
| Year | Start price | End price | NVO Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $50.88 | $43.07 | (11.30%) | +11.72% | (23.02%) |
| 2025 | $86.02 | $50.88 | (39.22%) | +17.72% | (56.94%) |
| 2024 | $103.45 | $86.02 | (15.93%) | +24.89% | (40.82%) |
| 2023 | $67.67 | $103.45 | +54.79% | +26.19% | +28.60% |
| 2022 | $56.00 | $67.67 | +22.65% | (18.17%) | +40.82% |
| 2021 | $34.92 | $56.00 | +63.41% | +28.74% | +34.67% |
| 2020 | $28.94 | $34.92 | +23.29% | +18.37% | +4.92% |
| 2019 | $23.04 | $28.94 | +28.64% | +31.22% | (2.58%) |
| 2018 | $26.84 | $23.04 | (11.88%) | (4.56%) | (7.32%) |
| 2017 | $17.93 | $26.84 | +54.32% | +21.70% | +32.62% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
